论文部分内容阅读
目的:评价胺碘酮对冠心病慢性心力衰竭伴室性心律失常患者的临床疗效。方法:选取2014年11月—2016年11月期间收治的冠心病慢性心力衰竭伴室性心律失常患者128例,按照随机数字表法将其分为对照组与观察组,每组64例;对照组患者给予吸氧、调脂等药物治疗,观察组患者在对照组基础上加用胺碘酮治疗,评价两组患者临床治疗后的疗效和治疗前后室性期前收缩次数与左室射血分数的变化情况。结果:观察组患者治疗后的总有效率为96.88%高于对照组为71.88%(P<0.05);两组患者治疗前室性期前收缩次数与左室射血分数经组间比较其差异无统计学意义(P>0.05),治疗后观察组患者室性期前收缩次数显著低于对照组,左室射血分数显著高于对照组(P<0.05)。结论:采用胺碘酮治疗冠心病慢性心力衰竭伴室性心律失常患者,可显著改善的心功能。
Objective: To evaluate the clinical effect of amiodarone on patients with coronary heart disease complicated with chronic heart failure and ventricular arrhythmia. Methods: A total of 128 CHD patients with heart failure and ventricular arrhythmias were enrolled from November 2014 to November 2016. The patients were divided into control group and observation group according to random number table method, with 64 cases in each group. Patients in the observation group were treated with amiodarone on the basis of the control group. The curative effect after treatment and the number of ventricular contractions before and after treatment were compared with left ventricular ejection Score changes. Results: The total effective rate of observation group after treatment was 96.88% higher than that of control group (71.88%) (P <0.05); before treatment, the number of premature ventricular contractions and left ventricular ejection fraction were compared between groups by the difference No statistical significance (P> 0.05). After treatment, the number of ventricular contractions in observation group was significantly lower than that in control group, and the left ventricular ejection fraction was significantly higher than that in control group (P <0.05). Conclusion: Amiodarone in patients with CHD complicated by chronic heart failure and ventricular arrhythmia can significantly improve cardiac function.